Court: Difference of Opinion is Not Hospice Fraud

The Eleventh Circuit Court of Appeals partially affirmed a decision in favor of Arkansas-based hospice provider AseraCare in False Claims Act (FCA) case that has widespread implications for the hospice industry. The appellate court agreed with the Northern District of Alabama that a mere difference of physician’s opinions on a terminal patient’s prognosis does not […]

VITAS Expands Florida Operations to Treasure Coast Region

VITAS Healthcare, a hospice subsidiary of Chemed Corp. (NYSE: CHE), has received two certificates of need in Florida, signaling that the company is expanding its operations across a region known as the Treasure Coast. The Miami-based hospice provider will also build a new 16-bed freestanding inpatient facility in southwest Miami-Dade County. In addition to hospice […]

CMS Proposed Rule Could Hurt Small Hospice Providers, Large Companies Unfazed 

National and regional hospice chains seem unfazed by proposed Medicare payment rebasing for fiscal year 2020—confident that the updates will not adversely affect their businesses—though smaller organizations may take a more significant hit. The U.S. Centers for Medicare & Medicaid Services (CMS) in late April released its annual proposed rule that outlines the agency’s regulatory […]

VITAS Margins Solid Despite Admissions Drop

VITAS Healthcare, the largest hospice provider in the United States, showed positive margins for the first quarter of 2019 despite a decline in admissions, according to a quarterly earnings report from its parent company, Chemed Corp. (NYSE: CME). VITAS’ gross margins for routine home care services reached 52.7 percent during the first quarter, a 60 […]